About Enhancer
| Enhancer ID: | E_02_0449 |
| Species: | human |
| Position : | chr17:44900435-44902435   |
| Biosample name: | |
| Experiment class : | High+Lowthroughput |
| Enhancer type: | Enhancer |
| Disease: | Alzheimer's disease (ad), atherosclerosis, cardiovascular disease, type 2 diabetes mellitus (t2dm) and metabolic syndrome (ms), obesity |
| Pubmed ID: | 30154946 |
| Enhancer experiment: | Immunofluorescence staining, statistical analysis, PCR |
| Enhancer experiment description: | In the same way, we observed an increment in interleukin-1?, TNF-?, and GFAP, indicative of exacerbated inflammatory processes by the combination of MS and A?1 42. |
About Target gene
| Target gene : | GFAP |
| Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
| Less strong evidence: | RNA-Seq |
| Target gene experiment description: | In the same way, we observed an increment in interleukin-1?, TNF-?, and GFAP, indicative of exacerbated inflammatory processes by the combination of MS and A?1 42. |
About TF
| TF name : | -- |
| TF experiment: | ??????,????,PCR |
| TF experiment description: | In the same way, we observed an increment in interleukin-1?, TNF-?, and GFAP, indicative of exacerbated inflammatory processes by the combination of MS and A?1 42. |
About Function
| Enhancer function : | In the same way, we observed an increment in interleukin-1?, TNF-?, and GFAP, indicative of exacerbated inflammatory processes by the combination of MS and A?1 42. |
| Enhancer function experiment: | Immunohistochemical staining |
| Enhancer function experiment description: |
In the same way, we observed an increment in interleukin-1?, TNF-?, and GFAP, indicative of exacerbated inflammatory processes by the combination of MS and A?1 42. |
About SNP
| SNP ID: | -- |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|
Enhancer associated network
The number on yellow line represents the distance between enhancer and
target gene